Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GEMTESA® safely and effectively. See full prescribing information for GEMTESA. GEMTESA (vibegron) tablets, for oral useInitial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
GEMTESA® is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. GEMTESA is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adult males on pharmacological therapy for benign prostatic hyperplasia (BPH).
- generic_name
- vibegron
- product_names
- vibegron
- ndc
- 73336-075, 73336-075-30, 73336-075-90, 73336-075-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en